Screener
Edwards Lifesciences EW Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Research and development expenses | 263.3 | 254.6 |
| Certain litigation expenses | 37.1 | 10.9 |
| Separation costs | — | 4.2 |
| Other operating income | (14.2) | (19.1) |
| Operating income, net | 477.6 | 394.8 |
| Interest income, net | (33.5) | (36.5) |
| Loss on impairment (Note 6) | 123.6 | — |
| Other non-operating income, net (Note7) | (71.5) | (2.6) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Edwards Lifesciences's other operating expenses?
- Edwards Lifesciences (EW) reported other operating expenses of $14.2M in Q1 2026.
- How has Edwards Lifesciences's other operating expenses changed year-over-year?
- Edwards Lifesciences's other operating expenses decreased by 25.7% year-over-year, from $19.1M to $14.2M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Edwards Lifesciences's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude